Gaylord Specialty Healthcare First in Nation to Adopt Ground-Breaking Pharyngeal Electrical Stimulation Technology to Treat Patients with Dysphagia featuring Phagenesis
WALLINGFORD, Conn., May 9, 2023 /PRNewswire/ — Gaylord Specialty Healthcare, a nonprofit rehabilitation-focused healthcare system, is proud to announce that it is the first healthcare organization in the nation to use the Phagenyx® Neurostimulation System from Phagenesis, Ltd. to treat dysphagia among stroke... Read More →
CardiaCare Names Ken Nelson Chairman of its Board of Directors
Digital health and medtech leader brings 20 years of cardiac innovation and commercialization experience to startup developing AI powered neuromodulation wearable for non-invasive atrial fibrillation treatment REHOVOT, Israel, May 8, 2023 /PRNewswire/ — CardiaCare, a clinical stage digital therapeutic company developing the world’s first... Read More →
Tricog Raises $8.5 Million In Series B2 Funding
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa Heart health AI firm Tricog has raised $8.5 million in a Series B2 funding round from OMRON... Read More →
Distalmotion raises $150M to accelerate FDA approval and clinical experience
Distalmotion announced today the first closing of its USD 150 million financing. This significant fundraise reinforces the confidence of its existing investors led by Revival Healthcare Capital. Dexter, Distalmotion’s robotic platform, is in day-to-day clinical use in Europe, successfully treating... Read More →
Xenocor Completes Oversubscribed $10 million Series A to Lead the Future of Laparoscopic Visualization
Led by GenHenn Venture Fund I, Xenocor will leverage the capital to facilitate launch and rapid adoption of the 5mm articulating Saberscope SALT LAKE CITY, April 18, 2023 /PRNewswire/ — Xenocor, creator of the FDA cleared Saberscope, the world’s first... Read More →
Candesant Biomedical Receives FDA Clearance of Brella™1, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
New Non-Invasive Treatment Significantly Reduces Excessive Underarm Sweating and Significantly Improves Quality of Life – Including Reducing the Negative Impact of Excessive Sweating on Daily Activities – After a Single In-Office Treatment FDA Clearance Based on Data from Randomized, Double-Blind,... Read More →
Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG
Designation represents progress for patients with suspected Coronary Microvascular Dysfunction as the FDA recognizes disease’s debilitating impacts and the lack of effective non-invasive options for efficient diagnosis MASON, Ohio–(BUSINESS WIRE)–Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced... Read More →
MY01, Inc. Receives $12.5M Funding to Accelerate Growth
MONTREAL, April 11, 2023 /PRNewswire/ – MY01, Inc., a medical technology company that uses microsensors to aid physicians in diagnosing compartment syndrome, today announced it has raised a $12.5 million USD Series A funding round. The round is led by... Read More →
EvoEndo CEO to leave, replacement named
EvoEndo announced today announced a new CEO and COO along with the departure of previous CEO Heather Underwood. Denver-based EvoEndo, which develops transnasal endoscopy technology, named Jonathan Hartmann as president and CEO. It appointed Ryan Hartman to the COO position.... Read More →
Prapela receives NIH Grant to improve the treatment of Apnea of Prematurity in collaboration with Tufts Medical Center and the University of Alabama at Birmingham
NIH Blueprint MedTech grant supports the development of a medical device that can improve the treatment of apnea in preterm newborns. Every year, about 1.6 million preterm newborns experience apnea of prematurity, or episodes where they stop breathing for more... Read More →